228 related articles for article (PubMed ID: 21780116)
1. Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) in combination with the Apogossypol derivative BI-97C1 (Sabutoclax) improves therapeutic efficacy in low CAR colorectal cancer cells.
Azab B; Dash R; Das SK; Bhutia SK; Shen XN; Quinn BA; Sarkar S; Wang XY; Hedvat M; Dmitriev IP; Curiel DT; Grant S; Dent P; Reed JC; Pellecchia M; Sarkar D; Fisher PB
J Cell Physiol; 2012 May; 227(5):2145-53. PubMed ID: 21780116
[TBL] [Abstract][Full Text] [Related]
2. Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) improves therapeutic efficacy in low CAR prostate cancer cells.
Dash R; Dmitriev I; Su ZZ; Bhutia SK; Azab B; Vozhilla N; Yacoub A; Dent P; Curiel DT; Sarkar D; Fisher PB
Cancer Gene Ther; 2010 Jul; 17(7):447-56. PubMed ID: 20150932
[TBL] [Abstract][Full Text] [Related]
3. Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity.
Dash R; Azab B; Quinn BA; Shen X; Wang XY; Das SK; Rahmani M; Wei J; Hedvat M; Dent P; Dmitriev IP; Curiel DT; Grant S; Wu B; Stebbins JL; Pellecchia M; Reed JC; Sarkar D; Fisher PB
Proc Natl Acad Sci U S A; 2011 May; 108(21):8785-90. PubMed ID: 21555592
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention gene therapy (CGT) of pancreatic cancer using perillyl alcohol and a novel chimeric serotype cancer terminator virus.
Sarkar S; Azab B; Quinn BA; Shen X; Dent P; Klibanov AL; Emdad L; Das SK; Sarkar D; Fisher PB
Curr Mol Med; 2014 Jan; 14(1):125-40. PubMed ID: 24236457
[TBL] [Abstract][Full Text] [Related]
5. Enhanced prostate cancer gene transfer and therapy using a novel serotype chimera cancer terminator virus (Ad.5/3-CTV).
Azab BM; Dash R; Das SK; Bhutia SK; Sarkar S; Shen XN; Quinn BA; Dent P; Dmitriev IP; Wang XY; Curiel DT; Pellecchia M; Reed JC; Sarkar D; Fisher PB
J Cell Physiol; 2014 Jan; 229(1):34-43. PubMed ID: 23868767
[TBL] [Abstract][Full Text] [Related]
6. Enhancing mda-7/IL-24 therapy in renal carcinoma cells by inhibiting multiple protective signaling pathways using sorafenib and by Ad.5/3 gene delivery.
Eulitt PJ; Park MA; Hossein H; Cruikshanks N; Yang C; Dmitriev IP; Yacoub A; Curiel DT; Fisher PB; Dent P
Cancer Biol Ther; 2010 Dec; 10(12):1290-305. PubMed ID: 20948318
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated suicide gene therapy under the control of Cox-2 promoter for colorectal cancer.
Wang ZX; Bian HB; Yang JS; De W; Ji XH
Cancer Biol Ther; 2009 Aug; 8(15):1480-8. PubMed ID: 19571664
[TBL] [Abstract][Full Text] [Related]
8. BI-69A11 enhances susceptibility of colon cancer cells to mda-7/IL-24-induced growth inhibition by targeting Akt.
Pal I; Sarkar S; Rajput S; Dey KK; Chakraborty S; Dash R; Das SK; Sarkar D; Barile E; De SK; Pellecchia M; Fisher PB; Mandal M
Br J Cancer; 2014 Jul; 111(1):101-11. PubMed ID: 24892445
[TBL] [Abstract][Full Text] [Related]
9. Combined transductional untargeting/retargeting and transcriptional restriction enhances adenovirus gene targeting and therapy for hepatic colorectal cancer tumors.
Li HJ; Everts M; Yamamoto M; Curiel DT; Herschman HR
Cancer Res; 2009 Jan; 69(2):554-64. PubMed ID: 19147569
[TBL] [Abstract][Full Text] [Related]
10. Acquired and innate resistance to the cancer-specific apoptosis-inducing cytokine, mda-7/IL-24: not insurmountable therapeutic problems.
Sarkar D; Dent P; Curiel DT; Fisher PB
Cancer Biol Ther; 2008 Jan; 7(1):109-12. PubMed ID: 18277093
[TBL] [Abstract][Full Text] [Related]
11. Therapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimetic.
Sarkar S; Quinn BA; Shen XN; Dash R; Das SK; Emdad L; Klibanov AL; Wang XY; Pellecchia M; Sarkar D; Fisher PB
Oncotarget; 2015 May; 6(13):10712-27. PubMed ID: 25926554
[TBL] [Abstract][Full Text] [Related]
12. The in vitro and in vivo antitumor activity of adenovirus-mediated interleukin-24 expression for laryngocarcinoma.
Liu J; Sheng W; Xie Y; Shan Y; Miao J; Xiang J; Yang J
Cancer Biother Radiopharm; 2010 Feb; 25(1):29-38. PubMed ID: 20187794
[TBL] [Abstract][Full Text] [Related]
13. Gene delivery into malignant glioma by infectivity-enhanced adenovirus: in vivo versus in vitro models.
Van Houdt WJ; Wu H; Glasgow JN; Lamfers ML; Dirven CM; Gillespie GY; Curiel DT; Haviv YS
Neuro Oncol; 2007 Jul; 9(3):280-90. PubMed ID: 17522331
[TBL] [Abstract][Full Text] [Related]
14. Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer.
Zhao L; Gu J; Dong A; Zhang Y; Zhong L; He L; Wang Y; Zhang J; Zhang Z; Huiwang J; Qian Q; Qian C; Liu X
Hum Gene Ther; 2005 Jul; 16(7):845-58. PubMed ID: 16000066
[TBL] [Abstract][Full Text] [Related]
15. A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway.
Tsuruta Y; Pereboeva L; Glasgow JN; Rein DT; Kawakami Y; Alvarez RD; Rocconi RP; Siegal GP; Dent P; Fisher PB; Curiel DT
Clin Cancer Res; 2007 May; 13(9):2777-83. PubMed ID: 17473211
[TBL] [Abstract][Full Text] [Related]
16. Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor.
Kaner RJ; Worgall S; Leopold PL; Stolze E; Milano E; Hidaka C; Ramalingam R; Hackett NR; Singh R; Bergelson J; Finberg R; Falck-Pedersen E; Crystal RG
Am J Respir Cell Mol Biol; 1999 Mar; 20(3):361-70. PubMed ID: 10030833
[TBL] [Abstract][Full Text] [Related]
17. Eradication of therapy-resistant human prostate tumors using a cancer terminator virus.
Sarkar D; Lebedeva IV; Su ZZ; Park ES; Chatman L; Vozhilla N; Dent P; Curiel DT; Fisher PB
Cancer Res; 2007 Jun; 67(11):5434-42. PubMed ID: 17545625
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated ING4/IL-24 double tumor suppressor gene co-transfer enhances antitumor activity in human breast cancer cells.
Zhao Y; Li Z; Sheng W; Miao J; Yang J
Oncol Rep; 2012 Oct; 28(4):1315-24. PubMed ID: 22842937
[TBL] [Abstract][Full Text] [Related]
19. The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer.
Zhao L; Dong A; Gu J; Liu Z; Zhang Y; Zhang W; Wang Y; He L; Qian C; Qian Q; Liu X
Cancer Gene Ther; 2006 Nov; 13(11):1011-22. PubMed ID: 16799468
[TBL] [Abstract][Full Text] [Related]
20. Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer.
Dehari H; Ito Y; Nakamura T; Kobune M; Sasaki K; Yonekura N; Kohama G; Hamada H
Cancer Gene Ther; 2003 Jan; 10(1):75-85. PubMed ID: 12489031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
